BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

526075

VINRKLB

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

REKVINA LABORATORIES LTD. Share Price Update

As of the latest trading session, REKVINA LABORATORIES LTD. share price is currently at ₹ 4.5, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 4.50 and ₹ 4.50. Over the past year, REKVINA LABORATORIES LTD. has achieved a return of 7.91 %. In the last month alone, the return has been [-] %. Read More...

Investment Returns

Over 1 Month 0.00% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

REKVINA LABORATORIES LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    0.0

  • P/E Ratio (TTM)

    0.0

  • Beta

    0.0

  • Book Value / share

    0.0

  • Return on equity

    0.0%

  • EPS (TTM)

    0.0

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.0

info icon alternate text

REKVINA LABORATORIES LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 0.20
Operating Expense 0.23
Net Profit -0.03
Net Profit Margin (%) -15.00
Earnings Per Share (EPS) 0.06
EBITDA -0.03
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.04
Net Profit -0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.05
EBITDA -0.04
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.04
Net Profit -0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.07
EBITDA -0.04
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.02
Net Profit -0.02
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.04
EBITDA -0.02
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.07
Net Profit -0.07
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.11
EBITDA -0.07
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.14
Net Profit -0.14
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.23
EBITDA -0.14
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.02
Net Profit -0.02
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.03
EBITDA -0.02
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.00
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.08
Net Profit -0.08
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.13
EBITDA -0.08
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.06
Net Profit -0.06
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.10
EBITDA -0.06
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share -0.55
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share -0.01
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 0.02
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 4.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 0.02
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 0.15
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 0.03
Total Liabilities 0.03
Total Equity -0.33
Share Outstanding 6028000
Price to Book Ratio 0.00
Return on Assets (%) -421.84
Return on Capital (%) 160.73
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.20
Total Liabilities 0.20
Total Equity 0.00
Share Outstanding 6028000
Price to Book Ratio 0.00
Return on Assets (%) -8.13
Return on Capital (%) -19
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.20
Total Liabilities 0.20
Total Equity 0.01
Share Outstanding 6028000
Price to Book Ratio 0.00
Return on Assets (%) -0.34
Return on Capital (%) -0.74
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.19
Total Liabilities 0.19
Total Equity 0.01
Share Outstanding 6028000
Price to Book Ratio 0.00
Return on Assets (%) -41.01
Return on Capital (%) -567.49
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.24
Total Liabilities 0.24
Total Equity 0.09
Share Outstanding 6028000
Price to Book Ratio 26.47
Return on Assets (%) -26.45
Return on Capital (%) -69.18
Particulars MAR 2025 (Values in Cr)
Net Income -0.13
Cash from Operations -0.19
Cash from Investing 0.00
Cash from Financing 0.20
Net change in Cash 0.01
Free Cash Flow -0.19
Particulars MAR 2024 (Values in Cr)
Net Income -0.01
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2023 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2022 (Values in Cr)
Net Income -0.07
Cash from Operations -0.03
Cash from Investing 0.03
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow -0.03
Particulars MAR 2021 (Values in Cr)
Net Income -0.06
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 30.76 15.08 1.59 235.72 30.00 / 68.00
BLISS GVS PHARMA LTD 161.90 15.61 1.62 1711.65 105.05 / 190.65
CIPLA LTD 1531.65 22.74 3.75 123722.28 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 291.85 7.67 2.19 858.94 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2477.90 44.04 24.58 41977.12 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 30.76 25.01 4.28 235.72 30.00 / 68.00
AMRUTAJAN HEALTH LTD 719.05 36.67 6.07 2078.82 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9155.10 99.01 28.64 22887.75 6222.35 / 10653.05
BLISS GVS PHARMA LTD 161.90 21.85 1.61 1711.65 105.05 / 190.65

REKVINA LABORATORIES LTD. shareholding pattern

Holding

Others
58.7%
Promoter Holdings
41.29%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Surbhit Mukesh Shah 917607.0 (15.22%) Shareholding of Promoter and Promoter Group
Amit Mukesh Shah 827883.0 (13.73%) Shareholding of Promoter and Promoter Group
Mukesh Jamnadas Shah 743993.0 (12.34%) Shareholding of Promoter and Promoter Group
Niravbhai Jashubhai Patel 389921.0 (6.47%) Public Shareholding
Dilsan Pharma Impex Private Limited 385773.0 (6.4%) Public Shareholding
Amitkumar Arunkumar Rao Huf 284550.0 (4.72%) Public Shareholding
Abhijit Dharmeshbhai Mehta 269000.0 (4.46%) Public Shareholding
Arunkumar Narsingh Rao 237000.0 (3.93%) Public Shareholding
Kishorbhai J Suratwala 229694.0 (3.81%) Public Shareholding
Khushali Nemish Badani 144175.0 (2.39%) Public Shareholding
Amitkumar Arunkumar Rao 99531.0 (1.65%) Public Shareholding
Nemishbhai Jayeshbhai Badani 90175.0 (1.5%) Public Shareholding
Pareshkumar Rameshchandra Patel 87109.0 (1.45%) Public Shareholding
Sanjay Bhanubhai Shah 65000.0 (1.08%) Public Shareholding

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

REKVINA LABORATORIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
4.50 0.00 redarrow
red-green-graph indicator
0 Bearish
0 Bullish
  • 5 Days 0.00
  • 26 Days 0.00
  • 10 Days 0.00
  • 50 Days 0.00
  • 12 Days 0.00
  • 100 Days 0.00
  • 20 Days 0.00
  • 200 Days 0.00
0.0 PIVOT

First Support

0.0

First Resistance

0.0

Second Support

0.0

Second Resistance

0.0

Third Support

0.0

Third Resistance

0.0

RSI

0.0

ADX

0.0

MACD

0.0

Williams % R

0.0

Commodity Channel Index (CCI)

0.0

Date

[-]

Week

0.0

Same Day

0.0

Month

0.0

1 Year

0.0

3 Year

0.0

Over 1 Month

0.00%

down

Over 1 Year

7.91%

down

Over 3 Months

12.78%

down

Over 3 Years

-3.77%

down

Over 6 Months

24.99%

down

Over 5 Years

-8.27%

down

REKVINA LABORATORIES LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
30 Apr 2014 10.0 5.0 02 May 2014

REKVINA LABORATORIES LTD. Share Price

Rekvina Labs Ltd was incorporated on 1st November 1988. The Company is registered in England and Wales as a Public Limited Company. The company is mainly engaged in manufacturing and marketing of pharmaceutical products. It presently operates into one business segment i.e. copper extrusion.

During FY2015, the company sub divided its existing equity shares in such a manner that every shareholder holding 1 equity share of Rs. 10/- each is issued 2 equity shares of Rs. 5/- each.

During the year 2017, the Company issued a total of 10,769,867 shares. Of this total, 9,043,518 shares were issued under the Mobeus VCTs' Linked Offer for Subscription launched on 10 December 2014; and 1,726,349 shares were issued under Company's Dividend Investment Scheme.

During the year 2017, the Company bought back 553,800 of its own shares at an average price of 95.28 pence per share and a total cost of 527,637 including expenses. These shares represented 0.9% of the issued share capital of Company at 1 October 2014. All shares bought back by Company during the year 2017 were subsequently cancelled.

Parent organization Indian Private
NSE symbol [-]
Founded 1988
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Rekvina Labs Ltd?

Answer Field

Rekvina Labs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 4.50 as on Dec 13 2021 12:00 AM.

What is the Market Cap of Rekvina Labs Ltd Share?

Answer Field

The market cap of Rekvina Labs Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Dec 13 2021 12:00 AM.

What is the 52 Week High and Low of Rekvina Labs Ltd?

Answer Field

The 52 Week High and Low of Rekvina Labs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 4.50 and ₹ 0.00.

What is 1 year return for Rekvina Labs Ltd?

Answer Field

The 1 year returns on the stock has been 7.91%.

What is the P/E Ratio of Rekvina Labs Ltd Share?

Answer Field

As on Dec 13 2021 12:00 AM the price-to-earnings (PE) ratio for Rekvina Labs Ltd share is 0.0.

What is the PB ratio of Rekvina Labs Ltd Share?

Answer Field

As on Dec 13 2021 12:00 AM, the price-to-book (PB) ratio for Rekvina Labs Ltd share is 0.0.

How to Buy Rekvina Labs Ltd Share?

Answer Field

You can trade in Rekvina Labs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Rekvina Labs Ltd Share on Bajaj Broking App?

Answer Field

To buy Rekvina Labs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Rekvina Labs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59